Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03837457
Title PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM)
Acronym PRISM
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors miRagen Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | BEL


No variant requirements are available.